Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02114073Phase 2Completed
A Phase 2 trial of cyclosporine 2% ophthalmic solution in open-angle glaucoma (OAG), sponsored by Mashhad University of Medical Sciences. Started Apr 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02114073.